• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.分子技术在艰难梭菌感染诊断中的应用:系统评价和荟萃分析。
Mayo Clin Proc. 2012 Jul;87(7):643-51. doi: 10.1016/j.mayocp.2012.02.024.
2
Low-complexity manual nucleic acid amplification tests for pulmonary tuberculosis in children.用于儿童肺结核的低复杂度手动核酸扩增检测
Cochrane Database Syst Rev. 2025 Jun 25;6(6):CD015806. doi: 10.1002/14651858.CD015806.pub2.
3
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
4
Accuracy of diagnostic assays for the detection of Clostridioides difficile: A systematic review and meta-analysis.用于检测艰难梭菌的诊断检测方法的准确性:一项系统评价和荟萃分析。
J Microbiol Methods. 2023 Jan;204:106657. doi: 10.1016/j.mimet.2022.106657. Epub 2022 Dec 15.
5
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).欧洲临床微生物学和传染病学会(ESCMID):艰难梭菌感染(CDI)诊断的数据回顾和建议。
Clin Microbiol Infect. 2009 Dec;15(12):1053-66. doi: 10.1111/j.1469-0691.2009.03098.x.
6
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
7
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌(艰难梭菌)。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
10
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.

引用本文的文献

1
Innovative nucleic acid detection of utilizing the PAM-unconventional, one-step LAMP/CRISPR-Cas12b detection platforms.利用PAM非传统一步式LAMP/CRISPR-Cas12b检测平台进行创新核酸检测。
Front Cell Infect Microbiol. 2025 May 29;15:1594271. doi: 10.3389/fcimb.2025.1594271. eCollection 2025.
2
Gastroenterological Surgery and Management of Infection: A Review.胃肠外科手术与感染管理:综述
J Anus Rectum Colon. 2025 Jan 25;9(1):25-32. doi: 10.23922/jarc.2024-078. eCollection 2025.
3
Comparison of the STANDARD M10 . , Xpert . , and BD MAX Cdiff assays as confirmatory tests in a two-step algorithm for diagnosing infection.将标准M10、Xpert和BD MAX艰难梭菌检测作为两步诊断算法中感染确认试验的比较。
Microbiol Spectr. 2025 Jan 7;13(1):e0166224. doi: 10.1128/spectrum.01662-24. Epub 2024 Nov 29.
4
Comparative evaluation of the STANDARD M10 and Xpert . assays for detection of toxigenic in stool specimens.比较评估 STANDARD M10 和 Xpert 检测粪便标本中产毒 的检测效果。
J Clin Microbiol. 2024 Jul 16;62(7):e0052424. doi: 10.1128/jcm.00524-24. Epub 2024 Jun 27.
5
A Case of Postoperative Methicillin-Resistant Staphylococcus aureus Enterocolitis in an 81-Year-Old Man and Review of the Literature.一名81岁男性术后耐甲氧西林金黄色葡萄球菌性小肠结肠炎病例及文献复习
Am J Case Rep. 2020 Sep 29;21:e922521. doi: 10.12659/AJCR.922521.
6
Evaluation of the Cost-effectiveness of Infection Control Strategies to Reduce Hospital-Onset Clostridioides difficile Infection.评价感染控制策略降低医院获得性艰难梭菌感染的成本效益。
JAMA Netw Open. 2020 Aug 3;3(8):e2012522. doi: 10.1001/jamanetworkopen.2020.12522.
7
Updated Management Guidelines for in Paediatrics.《儿科[具体病症未给出]的最新管理指南》
Pathogens. 2020 Apr 16;9(4):291. doi: 10.3390/pathogens9040291.
8
Molecular-based diagnostics, including future trends.基于分子的诊断方法,包括未来趋势。
Medicine (Abingdon). 2013 Nov;41(11):663-666. doi: 10.1016/j.mpmed.2013.08.012. Epub 2013 Oct 28.
9
Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR).艰难梭菌感染的诊断和治疗建议:西班牙化疗学会(SEQ)、西班牙内科学会(SEMI)和西班牙麻醉与复苏学会术后感染工作组(SEDAR)的官方临床实践指南。
Rev Esp Quimioter. 2020 Apr;33(2):151-175. doi: 10.37201/req/2065.2020. Epub 2020 Feb 20.
10
A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of () in Adults.一项关于核酸扩增检测(NAATs)和包括 NAATs 在内的算法在诊断成人()中的实验室医学最佳实践系统评价和荟萃分析。
Clin Microbiol Rev. 2019 May 29;32(3). doi: 10.1128/CMR.00032-18. Print 2019 Jun 19.

本文引用的文献

1
Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays with C. difficile nucleic acid amplification testing increase diagnostic yield in a tertiary pediatric population.采用谷氨酸脱氢酶抗原和艰难梭菌毒素酶免疫分析的艰难梭菌检测算法,联合艰难梭菌核酸扩增检测,可提高三级儿科人群的诊断产量。
J Clin Microbiol. 2012 Apr;50(4):1185-8. doi: 10.1128/JCM.05620-11. Epub 2012 Jan 18.
2
Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.环介导等温扩增与实时 PCR 和酶免疫分析检测产毒艰难梭菌的比较。
J Clin Microbiol. 2012 Mar;50(3):640-5. doi: 10.1128/JCM.01014-11. Epub 2011 Dec 21.
3
Prospective evaluation of the Meridian Illumigene™ loop-mediated amplification assay and the Gen Probe ProGastro™ Cd polymerase chain reaction assay for the direct detection of toxigenic Clostridium difficile from fecal samples.前瞻性评估 Meridian Illumigene™ 环介导扩增检测法和 Gen Probe ProGastro™ Cd 聚合酶链反应检测法,用于直接从粪便样本中检测产毒艰难梭菌。
Diagn Microbiol Infect Dis. 2012 Jan;72(1):8-13. doi: 10.1016/j.diagmicrobio.2011.09.008. Epub 2011 Oct 19.
4
Detection of Clostridium difficile toxin A/B genes by multiplex real-time PCR for the diagnosis of C. difficile infection.采用多重实时 PCR 检测艰难梭菌毒素 A/B 基因用于艰难梭菌感染的诊断。
J Med Microbiol. 2012 Feb;61(Pt 2):274-277. doi: 10.1099/jmm.0.035618-0. Epub 2011 Sep 29.
5
Detection of toxigenic Clostridium difficile in pediatric stool samples: an evaluation of Quik Check Complete Antigen assay, BD GeneOhm Cdiff PCR, and ProGastro Cd PCR assays.检测儿科粪便样本中的产毒艰难梭菌:对 Quik Check Complete 抗原检测、BD GeneOhm Cdiff PCR 和 ProGastro Cd PCR 检测方法的评估。
Diagn Microbiol Infect Dis. 2011 Nov;71(3):224-9. doi: 10.1016/j.diagmicrobio.2011.07.015. Epub 2011 Sep 6.
6
Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile Infection: a meta-analysis.实时聚合酶链反应检测疑似艰难梭菌感染患者粪便样本中艰难梭菌的诊断准确性:一项荟萃分析。
Clin Infect Dis. 2011 Oct;53(7):e81-90. doi: 10.1093/cid/cir505.
7
Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.艰难梭菌感染酶免疫检测阴性的临床和感染控制意义。
Clin Infect Dis. 2011 Aug 1;53(3):287-90. doi: 10.1093/cid/cir361.
8
Comparison of five assays for detection of Clostridium difficile toxin.五种检测艰难梭菌毒素方法的比较。
J Mol Diagn. 2011 Jul;13(4):395-400. doi: 10.1016/j.jmoldx.2011.03.004. Epub 2011 Apr 29.
9
Effective utilization of evolving methods for the laboratory diagnosis of Clostridium difficile infection.有效利用不断发展的方法进行艰难梭菌感染的实验室诊断。
Clin Infect Dis. 2011 Jun 15;52(12):1451-7. doi: 10.1093/cid/cir201.
10
Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections.评估环介导等温扩增检测技术用于诊断艰难梭菌感染。
J Clin Microbiol. 2011 Jul;49(7):2714-6. doi: 10.1128/JCM.01835-10. Epub 2011 Apr 27.

分子技术在艰难梭菌感染诊断中的应用:系统评价和荟萃分析。

Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis.

机构信息

Department of Graduate Medical Education, Aurora UW Medical Group, Milwaukee, WI, USA.

出版信息

Mayo Clin Proc. 2012 Jul;87(7):643-51. doi: 10.1016/j.mayocp.2012.02.024.

DOI:10.1016/j.mayocp.2012.02.024
PMID:22766084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3538482/
Abstract

OBJECTIVE

To assess the usefulness of 2 rapid molecular diagnostic techniques, polymerase chain reaction (PCR) and loop-mediated isothermal amplification (LAMP), in Clostridium difficile infection (CDI).

METHODS

We conducted a systematic review and meta-analysis to evaluate the accuracy of PCR and LAMP in diagnosis of CDI, including studies that used toxigenic culture or cytotoxicity assay as reference standard.

RESULTS

A search of PubMed and CinAHL medical databases yielded 25 PCR studies, including 11,801 samples that met inclusion criteria and 6 heterogeneous studies that evaluated LAMP. With toxigenic culture as a standard, pooled sensitivity was 0.92 (95% confidence interval [CI], 0.91-0.94); specificity, 0.94 (95% CI, 0.94-0.95); and diagnostic odds ratio, 378 (95% CI, 260-547). With cytotoxicity as a standard, pooled sensitivity was 0.87 (95% CI, 0.84-0.90); specificity, 0.97 (95% CI, 0.97-0.98); and diagnostic odds ratio, 370 (95% CI, 226-606).

CONCLUSION

Polymerase chain reaction is a highly accurate test for identifying CDI. Heterogeneity in LAMP studies did not allow meta-analysis; however, further research into this promising method is warranted.

摘要

目的

评估聚合酶链反应(PCR)和环介导等温扩增(LAMP)两种快速分子诊断技术在艰难梭菌感染(CDI)中的应用价值。

方法

我们进行了系统评价和荟萃分析,以评估 PCR 和 LAMP 诊断 CDI 的准确性,包括使用产毒培养或细胞毒性测定作为参考标准的研究。

结果

对 PubMed 和 CinAHL 医学数据库的搜索共得到 25 项 PCR 研究,包括符合纳入标准的 11801 个样本和 6 项评估 LAMP 的异质性研究。以产毒培养为标准,合并敏感性为 0.92(95%置信区间 [CI],0.91-0.94);特异性为 0.94(95% CI,0.94-0.95);诊断比值比为 378(95% CI,260-547)。以细胞毒性测定为标准,合并敏感性为 0.87(95% CI,0.84-0.90);特异性为 0.97(95% CI,0.97-0.98);诊断比值比为 370(95% CI,226-606)。

结论

PCR 是一种高度准确的 CDI 检测方法。LAMP 研究的异质性不允许进行荟萃分析;然而,需要进一步研究这种有前途的方法。